ARCHIVES

PSA Velocity Poor Predictor Of Prostate Cancer Occurrence

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

In the States: Michigan to Allocate $50 Million Annually To Life Sciences

July 23, 1999

In Brief: NCI To Supply Maytansine For Several Phase I Studies; Holleb Urges Referrals To “Experts”

March 26, 1976

FDA, NCI Seek Compromise On Survival Endpoints

June 16, 1989

Genasense Added To Chemo Improves Responses in CLL

December 31, 2004

Health Organizations: ACS Advises annual Prostate Screening for some Younger Men

June 20, 1997

Bishop: Scientists Need Seat At NCI Executive Committee, More Voice In Decision Making

February 24, 1995